Your browser doesn't support javascript.
loading
Clinicopathological features and prognostic significance of programmed death ligand 1 in pediatric ALK-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan.
Iwafuchi, Hideto; Nakazawa, Atsuko; Sekimizu, Masahiro; Mori, Tetsuya; Osumi, Tomoo; Iijima-Yamashita, Yuka; Ohki, Kentaro; Kiyokawa, Nobutaka; Fukano, Reiji; Saito, Akiko M; Horibe, Keizo; Kobayashi, Ryoji.
Afiliación
  • Iwafuchi H; Department of Pathology, Shizuoka Children's Hospital, Shizuoka, 420-8660, Japan; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, 460-0001, Japan; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Develo
  • Nakazawa A; Department of Clinical Research, Saitama Children's Medical Center, Saitama, 330-8777, Japan.
  • Sekimizu M; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, 460-0001, Japan; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, 460-0001, Japan.
  • Mori T; Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, 216-8511, Japan.
  • Osumi T; Children's Cancer Center, National Center for Child Health and Development, Tokyo, 157-8535, Japan.
  • Iijima-Yamashita Y; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, 460-0001, Japan.
  • Ohki K; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, 157-8535, Japan.
  • Kiyokawa N; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, 157-8535, Japan.
  • Fukano R; Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, 755-8505, Japan.
  • Saito AM; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, 460-0001, Japan.
  • Horibe K; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, 460-0001, Japan; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, 460-0001, Japan.
  • Kobayashi R; Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, 003-0006, Japan.
Hum Pathol ; 116: 112-121, 2021 10.
Article en En | MEDLINE | ID: mdl-34363798
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Anaplásico de Células Grandes / Microambiente Tumoral / Antígeno B7-H1 Tipo de estudio: Guideline / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Anaplásico de Células Grandes / Microambiente Tumoral / Antígeno B7-H1 Tipo de estudio: Guideline / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2021 Tipo del documento: Article